Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
RESEARCH TOOLSreports
Holding DRMA?
Track your performance easily
DRMA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.05 - $13.36
Previous Close$1.15
Volume78.80K
Average Volume (3M)535.23K
Market Cap
$2.20M
Enterprise Value$2.35M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Mar 31, 2025EPS Estimate
-$1.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-21.42
Shares Outstanding2,040,768
10 Day Avg. Volume120,132
30 Day Avg. Volume535,231
Standard Deviation0.21
R-Squared0.03
Alpha-0.15
Financial Highlights & Ratios
Price to Book (P/B)0.71
Price to Sales (P/S)0.32
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.34
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Dermata Therapeutics News
PremiumMarket News
3 Penny Stocks to Watch Now, 8/6/24
DRMA FAQ
What was Dermata Therapeutics’s price range in the past 12 months?
Dermata Therapeutics lowest stock price was $1.05 and its highest was $13.36 in the past 12 months.
What is Dermata Therapeutics’s market cap?
Currently, no data Available
When is Dermata Therapeutics’s upcoming earnings report date?
Dermata Therapeutics’s upcoming earnings report date is Mar 31, 2025 which is in 129 days.
How were Dermata Therapeutics’s earnings last quarter?
Dermata Therapeutics released its earnings results on Nov 13, 2024. The company reported -$2.04 earnings per share for the quarter, beating the consensus estimate of -$2.64 by $0.6.
Is Dermata Therapeutics overvalued?
According to Wall Street analysts Dermata Therapeutics’s price is currently Overvalued.
Does Dermata Therapeutics pay dividends?
Dermata Therapeutics does not currently pay dividends.
What is Dermata Therapeutics’s EPS estimate?
Dermata Therapeutics’s EPS estimate is -$1.36.
How many shares outstanding does Dermata Therapeutics have?
Dermata Therapeutics has 2,040,768 shares outstanding.
What happened to Dermata Therapeutics’s price movement after its last earnings report?
Dermata Therapeutics reported an EPS of -$2.04 in its last earnings report, beating expectations of -$2.64. Following the earnings report the stock price went down -3.252%.
Which hedge fund is a major shareholder of Dermata Therapeutics?
Currently, no hedge funds are holding shares in DRMA
---
Dermata Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.29%
12-Months-Change
Fundamentals
Return on Equity
-202.20%
Trailing 12-Months
Asset Growth
-8.69%
Trailing 12-Months
Company Description
Dermata Therapeutics
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
---
DRMA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering DRMA
1 Year
1 Year Success Rate
0/15 ratings generated profit
1 Year Average Return
-81.54%
reiterated a buy rating 3 months ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -81.54% per trade.
---